# Indraprastha Medical Corporation Ltd (INDRAMEDCO)
> Exchange: NSE | Sector: Pharma | ISIN: 

## Price
Current Price: ₹363.65
Day Change: +1.35%
52W High: ₹640.85
52W Low: ₹342
Market Cap: ₹3,301 Cr

## Valuation
P/E: 18.07
P/B: 5.01
EPS: ₹19.93
Book Value: ₹71.88
Dividend Yield: 0%

## Returns
1Y Return: -34.54%

## Profitability
ROE: 0%
ROCE: 39.02%
Debt/Equity: 0.05
Revenue Growth: 14.4%
Profit Growth: 24.9%
EBITDA Margin: 18.46%
Operating Margin: 13.64%

## About
Indraprastha Medical Corporation Ltd is a Medical Care Facilities company listed on NSE. The page combines exchange quotes, financial statements, shareholding, filings, and news so investors can review the business in one place.
Sector: Pharma
Industry: Medical Care Facilities
Sub Industry: Unknown

## Business Model
Overview: Indraprastha Medical Corporation Ltd makes money through Domestic formulations, Exports and regulated markets, Specialty or institutional sales in Medical Care Facilities. Revenue quality depends on demand growth, margin discipline, balance-sheet strength, and the company's ability to defend its position within Pharma.
Source: Derived from stock data
Revenue Streams:
- Domestic formulations
- Exports and regulated markets
- Specialty or institutional sales
Operating Model:
- Develops, manufactures, distributes, or services healthcare products across regulated channels.
- Approvals, product mix, compliance quality, and R&D productivity shape growth.
Recent Context:
- Announcement: Announcement under Regulation 30 (LODR)-Newspaper Publication
- Announcement: Board Meeting Outcome for OUTCOME OF THE BOARD MEETING
- BSE Filing: Announcement under Regulation 30 (LODR)-Newspaper Publication

## Access
Current tier: anonymous
More history: Register free to see 1 more year.

## Data Freshness
Quote Updated: 2026-05-25T12:00:11.977Z
Price History Updated: 2026-05-25T05:31:26.419Z
Latest Price History Date: 2026-05-24
Technicals Updated: 2026-05-25T05:31:26.419Z
Quant Updated: 2026-05-25T05:31:26.419Z
Sentiment Updated: 2026-05-25T05:31:26.419Z
Financials Status: current
Financials Updated: 2026-05-18T15:30:21.784Z
Financials Last Attempt: 2026-05-18T15:30:21.784Z
Financials Provider Tried: yahoo
Latest P&L Period: FY25
Latest Balance Sheet Period: FY25
Latest Cash Flow Period: FY25

## P&L (FY25)
Revenue: ₹1306.95 Cr
Operating Profit: ₹210.03 Cr (OPM 16.07%)
Net Profit: ₹160.99 Cr
Tax: ₹55.33 Cr

## Annual P&L History
FY25: Rev ₹1306.95Cr | PAT ₹160.99Cr | OPM 16.07%
FY24: Rev ₹1204.06Cr | PAT ₹123.96Cr | OPM 13.63%
FY23: Rev ₹1064.95Cr | PAT ₹86.15Cr | OPM 10.55%

## Balance Sheet (FY25)
Total Assets: ₹851.62 Cr
Total Liabilities: ₹254.94 Cr
Borrowings: ₹32.76 Cr
Cash: ₹61.48 Cr

## Shareholding
undefined: undefined%
undefined: undefined%
undefined: undefined%
undefined: undefined%
undefined: undefined%
undefined: undefined%
undefined: undefined%
undefined: undefined%
undefined: undefined%
undefined: undefined%
undefined: undefined%

## Board
- Shivakumar  Pattabhiraman ACA, B Com, CWA, Grad., MD & Additional Director
- Chander Prakash Tyagi, Chief Financial Officer
- Priya  Ranjan, Company Secretary & Compliance Officer

---
Source: rupiya.io/stocks/indramedco
Disclaimer: For research and education only. Not investment advice.